cultivate(MD) - cultivate(MD)

Shoulder Innovations a cultivate(MD) portfolio company

Shoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial Results

Press Release / March 10, 2026

Shoulder Innovations, Inc. (NYSE: SI), a cultivate(MD) portfolio company reported financial results for the fourth quarter and full year ended December 31, 2025. Financial Highlights Full Year and Recent Business Highlights “2025 was a transformational year for Shoulder Innovations. We continued to add new surgeon customers at an accelerated pace, drove rapid commercial adoption of […]

Shoulder Innovations Reports Fourth Quarter and Full Year 2025 Financial Results Read More »

Nanochon closes $4.1M Seed Prime II Funding Round

News / January 12, 2026

Nanochon, a cultivate(MD) portfolio company developing an implant for treating articular cartilage defects in the knee, has secured commitments to close an oversubscribed funding round, bringing its total capital raised to date to $11.3 million. The round was led by cultivate (MD), with significant contributions from The University of Virginia UVA Seed Fund, WSGR, Wealthing

Nanochon closes $4.1M Seed Prime II Funding Round Read More »

Prana Surgical Completes First Clinical Procedures Using the Prana System™ in Early Feasibility Study

News / January 7, 2026

First-in-human procedures mark a critical milestone supporting the system’s clinical development Prana Surgical, a cultivate(MD) portfolio company, announced the completion of the first five clinical procedures using the Prana System™ as part of its early feasibility study in Australia. The Prana System™ has been developed to enable image-guided, minimally invasive surgery, conserving healthy tissue and

Prana Surgical Completes First Clinical Procedures Using the Prana System™ in Early Feasibility Study Read More »

Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty

News / December 3, 2025

Partnership will Expand Shoulder Innovations’ Disruptive Ecosystem with Advanced Enabling Technology, Complementing Surgeon and Patient Needs in the ASC Shoulder Innovations (NYSE: SI), a cultivate(MD) portfolio company, today announced a strategic partnership with Interventional Systems (INS), a developer of robotic solutions for minimally invasive surgery, to introduce a transformative shoulder-specific micro-robotic solution designed to further

Shoulder Innovations Announces Strategic Partnership with INS to Introduce a Robotic Platform for Shoulder Arthroplasty Read More »

HAPPE Spine Reaches 1,000 Patients

News / November 13, 2025

HAPPE Spine, a cultivate(MD) portfolio company with a proprietary biomaterial and manufacturing platform for creating bone-integrating implants, announces that the INTEGRATE®-C Interbody Fusion System has been implanted in more than 1,000 patients, demonstrating clinical adoption of the HAPPE® platform across more than 30 surgeon users and 40 facilities nationwide.

HAPPE Spine Reaches 1,000 Patients Read More »

Shoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance

News / November 12, 2025

Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a cultivate(MD) portfolio company reported financial results for the third quarter ended September 30, 2025. Third Quarter & Recent Business Highlights “We are very excited about our accelerating momentum through 2025, with first-half year-over-year revenue growth of 37% expanding to 58% in the third quarter,

Shoulder Innovations Reports Third Quarter 2025 Financial Results and Increases Full-Year Revenue Guidance Read More »

Author name: cultivate(MD)